サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1485739

ライブバイオセラピューティクス製品および微生物CDMO市場：サービスタイプ別、オペレーション規模別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測

Live Biotherapeutics Products & Microbe CDMO Market, By Service Type, By Scale of Operation, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 290 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
ライブバイオセラピューティクス製品および微生物CDMO市場：サービスタイプ別、オペレーション規模別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年05月11日
発行: AnalystView Market Insights
ページ情報: 英文 290 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ライブバイオセラピューティクス製品および微生物CDMO市場規模は2023年に2,034万米ドルと評価され、2024年から2032年にかけてCAGR 40.5%で拡大

生きたバイオ治療製品・微生物CDMO市場-市場力学

次世代ライブバイオセラピューティクスとマイクロバイオーム受託製造における研究開発イニシアチブの進展

次世代ライブバイオセラピューティクスとマイクロバイオーム受託製造における研究開発イニシアチブの進展は、治療開発を再構築しています。例えば、米国国立衛生研究所（NIH）はマイクロバイオーム研究に多額の資金を割り当てており、医療イノベーションにおけるその重要性を強調しています。さらに、セレス・セラピューティクス（Seres Therapeutics）やヴェーダンタ・バイオサイエンシズ（Vedanta Biosciences）のような大手バイオ医薬品企業は、新規の生きたバイオ治療薬候補を開発しており、マイクロバイオームベースの治療法の可能性を強調しています。カリフォルニア大学サンディエゴ校とSGI-DNAによる合成生物学ソリューションの提携など、学術機関とCDMOのコラボレーションは、微生物に焦点を当てた製造における先端技術の統合が進んでいることを示しています。このような努力は、個別化された、マイクロバイオーム標的の治療薬への変革的なシフトを強調するものであり、幅広い臨床的意味を持っています。

生きたバイオ治療製品と微生物CDMO市場-主要な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約40.5%のCAGRで毎年成長すると予測されています。

サービスタイプ別では、製造サービスが2023年に最大市場シェアを示すと予測されています。

事業規模別では、2023年に臨床スケール事業が主要なタイプでした。

地域別では、北米が2023年に収益でリードしました。

ライブバイオセラピューティクス製品および微生物市場のセグメンテーション分析：

世界のライブバイオセラピューティクス製品および微生物CDMO市場は、サービスタイプ、事業規模、用途、地域に基づいてセグメント化されます。

市場はサービスタイプに基づいて2つのカテゴリーに分けられます：開発サービス」と「製造サービス」です。消費者は通常、開発サービスよりも製造サービスを優先します。これは、生きたバイオ治療薬の製造には専門的な製造能力が不可欠であるためです。効率的でスケーラブルな製造プロセスは、微生物ベースの治療法の商業化と市場供給に不可欠です。

市場は事業規模により3つのカテゴリーに分類される：前臨床スケール事業、臨床スケール事業、商業スケール事業です。通常、臨床規模での事業が優先され、次いで商業規模での事業、そして前臨床規模での事業の順となります。臨床スケール業務は、製品開発を薬事承認と商業化に向けて進めるために不可欠であり、商業スケール業務は、ライブ・バイオセラピューティクスの市場供給とスケーラビリティを確保するものです。

生きたバイオ治療製品・微生物CDMO市場-地理的洞察

北米は、大手製薬企業やバイオテクノロジー企業による微生物ベースの治療法に関する旺盛な研究開発活動や投資に牽引され、突出した地位を占めています。欧州は、確立された規制の枠組みが生きたバイオ治療薬とCDMOサービスの技術革新を支えており、これに続いています。アジア太平洋地域は、ヘルスケア支出の増加、先端バイオテクノロジーの採用の増加、国内外企業間のパートナーシップの拡大を背景に、急速な成長の可能性を示しています。この地域の新興経済諸国、特に中国やインドなどでは、微生物に焦点を当てた研究開発が急増しており、市場拡大に寄与しています。

ライブバイオセラピューティクス製品および微生物CDMO市場-競合情勢：

Lonza Group、Charles River Laboratories、Catalentなどの主な企業が最前線に立ち、生きたバイオ治療薬の開発と製造のための包括的なCDMOサービスを提供しています。Seres TherapeuticsとVedanta Biosciencesは、様々な適応症に対する微生物ベースの治療に焦点を当てた、ライブバイオセラピューティクス製品でリードしています。BacteriaとSeres Therapeuticsのような商業的製造のための提携は、製造能力を強化し、市場リーチを拡大するためのパートナーシップの傾向を強調しています。SBTインスツルメンツのような新興企業が革新的な技術を提供する一方で、既存企業は微生物に焦点を当てた治療法と受託製造サービスの未来を再定義するために研究開発に投資しています。この競合情勢は、技術革新を推進し、高度な生きたバイオ治療製品とCDMOソリューションに対する需要の高まりに対応するための継続的な努力を強調しています。複数の企業が革新的な生きたバイオ治療薬の開発と製造のために協力しています。例えば、2019年10月、4D Pharma plcは、ワクチン用のライブバイオセラピューティック製品（LBP）を発見・開発するためのMSD、メルク・アンド・カンパニー・インクとの研究協力およびライセンス契約を発表しました。

目次

第1章 ライブバイオセラピューティクス製品および微生物CDMO市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ライブバイオセラピューティクス製品および微生物CDMOの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ライブバイオセラピューティクス製品および微生物CDMO産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ライブバイオセラピューティクス製品および微生物CDMO市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ライブバイオセラピューティクス製品および微生物CDMO市場情勢

  • ライブバイオセラピューティクス製品および微生物CDMO市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ライブバイオセラピューティクス製品および微生物CDMO市場：サービスタイプ別

  • 概要
    • サービスタイプ別セグメントシェア分析
    • 開発サービス
    • 製造サービス
    • その他

第8章 ライブバイオセラピューティクス製品および微生物CDMO市場：事業規模別

  • 概要
    • 事業規模別セグメントシェア分析
    • 前臨床規模の運用
    • 臨床規模の運用
    • 商業規模の運用

第9章 ライブバイオセラピューティクス製品および微生物CDMO市場：用途別

  • 概要
    • 用途別セグメントシェア分析
    • C.ディフィシル
    • クローン病
    • IBS
    • 糖尿病
    • その他

第10章 ライブバイオセラピューティクス製品および微生物CDMO市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ライブバイオセラピューティクス製品および微生物CDMO業界

  • 競合ダッシュボード
  • 企業プロファイル
    • 4D Pharma PLC
    • Catalent, Inc.
    • Chr. Hansen Holding A/S
    • Evelo Biosciences, Inc.
    • Evonik Industries AG
    • Ferring Pharmaceuticals
    • Lonza Group AG
    • Microbiotica Ltd.
    • Pivot Bio
    • Rebiotix, Inc.（a Ferring Pharmaceuticals company）
    • Samsung Biologics
    • Second Genome, Inc.
    • Seres Therapeutics, Inc.
    • Synlogic, Inc.
    • Vedanta Biosciences, Inc.
    • Wacker Chemie AG
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Live Biotherapeutics Products & Microbe CDMO Market: Service Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Service Type 2019-2032 (USD Million)
  • TABLE Live Biotherapeutics Products & Microbe CDMO Market: Scale of Operation Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Scale of Operation
  • TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation 2019-2032 (USD Million)
  • TABLE Live Biotherapeutics Products & Microbe CDMO Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Application 2019-2032 (USD Million)
  • TABLE Live Biotherapeutics Products & Microbe CDMO Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Live Biotherapeutics Products & Microbe CDMO Market, by Region 2019-2032 (USD Million)
  • TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
  • TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
  • TABLE North America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
  • TABLE Europe Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
  • TABLE Asia Pacific Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
  • TABLE Latin America Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Scale of Operation, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Live Biotherapeutics Products & Microbe CDMO Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2637

REPORT HIGHLIGHT

Live Biotherapeutics Products & Microbe CDMO Market size was valued at USD 20.34 million in 2023, expanding at a CAGR of 40.5% from 2024 to 2032.

The Live Biotherapeutics Products & Microbe CDMO market involves developing, manufacturing, and commercializing therapeutic products based on live microbes for medical applications. The increasing demand for microbiome-based therapies is driven by awareness of the microbiome's role in health, advancements in microbial engineering enabling customized therapeutics, and the rising prevalence of chronic diseases facilitating market entry. However, challenges such as the complexity of microbiome research, manufacturing scalability issues, safety concerns, and limited market understanding pose restraints on market growth. Opportunities lie in expanding therapeutic applications beyond gastrointestinal disorders, increased R&D investment in microbiome therapeutics, and personalized medicine approaches enhancing targeted treatment strategies in healthcare.

Live Biotherapeutics Products & Microbe CDMO Market- Market Dynamics

Advancing R&D Initiatives in Next-Generation Live Biotherapeutics and Microbiome Contract Manufacturing

Advancing R&D initiatives in next-generation live biotherapeutics and microbiome contract manufacturing are reshaping therapeutic development. For instance, the National Institutes of Health (NIH) has allocated significant funding towards microbiome research, highlighting its importance in healthcare innovation. Additionally, leading biopharmaceutical companies like Seres Therapeutics and Vedanta Biosciences are pioneering novel live biotherapeutic candidates, emphasizing the potential of microbiome-based therapies. Collaborations between academic institutions and CDMOs, such as the partnership between the University of California, San Diego, and SGI-DNA for synthetic biology solutions, showcase the growing integration of advanced technologies in microbiome-focused manufacturing. These efforts underscore a transformative shift towards personalized, microbiome-targeted therapeutics with broad clinical implications.

Live Biotherapeutics Products & Microbe CDMO Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.5% over the forecast period (2024-2032)

Based on Service Type segmentation, Manufacturing Services was predicted to show maximum market share in the year 2023

Based on the Scale of Operation segmentation, Clinical Scale Operations was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Live Biotherapeutics Products & Microbe CDMO Market- Segmentation Analysis:

The Global Live Biotherapeutics Products & Microbe CDMO Market is segmented based on Service Type, Scale of Operation, Application, and Region.

The market is divided into two categories based on Service Type: Development Services and Manufacturing Services. Consumers typically prioritize Manufacturing Services over Development Services due to the critical need for specialized manufacturing capabilities in producing live biotherapeutic products. Efficient and scalable manufacturing processes are essential for the commercialization and market supply of microbiome-based therapies.

The market is divided into three categories based on Scale of Operation: Preclinical Scale Operations, Clinical Scale Operations, and Commercial Scale Operations. Operations typically prioritize Clinical Scale Operations followed by Commercial Scale Operations and then Preclinical Scale Operations. Clinical scale operations are critical for advancing product development towards regulatory approval and commercialization, while commercial scale operations ensure market supply and scalability of live biotherapeutics.

Live Biotherapeutics Products & Microbe CDMO Market- Geographical Insights

North America holds a prominent position, driven by robust R&D activities and investments in microbiome-based therapies by leading pharmaceutical and biotechnology companies. Europe follows closely, with established regulatory frameworks supporting innovation in live biotherapeutics and CDMO services. Asia Pacific showcases rapid growth potential, attributed to increasing healthcare expenditure, rising adoption of advanced biotechnology, and growing partnerships between local and international players. Emerging economies in this region, particularly in countries like China and India, are witnessing a surge in microbiome-focused research and development, contributing to market expansion.

Live Biotherapeutics Products & Microbe CDMO Market- Competitive Landscape:

Key players like Lonza Group, Charles River Laboratories, and Catalent are at the forefront, offering comprehensive CDMO services for live biotherapeutics development and manufacturing. Seres Therapeutics and Vedanta Biosciences lead in live biotherapeutics products, focusing on microbiome-based therapies for various indications. Collaborations such as Bacteria and Seres Therapeutics for commercial manufacturing highlight the trend towards partnerships to enhance manufacturing capabilities and expand market reach. Emerging companies like SBT Instruments contribute innovative technologies, while established players invest in R&D to redefine the future of microbiome-focused therapies and contract manufacturing services. This competitive landscape underscores ongoing efforts to drive innovation and meet the growing demand for advanced live biotherapeutic products and CDMO solutions. Several companies are collaborating for the development and production of innovative live biotherapeutics. For instance, in October 2019, 4D Pharma plc announced a research collaboration and licensing agreement with MSD, Merck & Co., Inc., to discover and develop Live Biotherapeutic Products (LBPs) for vaccines.

Recent Developments:

In June 2023, Biose Industrie and SBT Instruments collaborated to integrate rapid viable cell counts into Biose's manufacturing, setting a new standard for microbe enumeration. This integration aims to expedite clinical trials and market approval for Biose's live biotherapeutic products.

In November 2021, Bacthera and Seres Therapeutics are collaborating to manufacture SER-109, Seres' lead product candidate for recurrent Clostridioides difficile infection (CDI). Bacthera is establishing a dedicated commercial manufacturing facility within its new Microbiome Center of Excellence located on Lonza's Ibex campus in Visp, Switzerland.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

4D Pharma PLC

Catalent, Inc.

Chr. Hansen Holding A/S

Evelo Biosciences, Inc.

Evonik Industries AG

Ferring Pharmaceuticals

Lonza Group AG

Microbiotica Ltd.

Pivot Bio

Rebiotix, Inc. (a Ferring Pharmaceuticals company)

Samsung Biologics

Second Genome, Inc.

Seres Therapeutics, Inc.

Synlogic, Inc.

Vedanta Biosciences, Inc.

Wacker Chemie AG

Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Development Services
  • Manufacturing Services
  • Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

  • Preclinical Scale Operations
  • Clinical Scale Operations
  • Commercial Scale Operations

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • C.difficle
  • Crohn's disease
  • IBS
  • Diabetes
  • Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Live Biotherapeutics Products & Microbe CDMO Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Service Type
    • 2.1.2.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Scale of Operation
    • 2.1.3.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Application
    • 2.1.4.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Country
    • 2.1.5.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Region
  • 2.2.Competitive Insights

3.Live Biotherapeutics Products & Microbe CDMO Key Market Trends

  • 3.1.Live Biotherapeutics Products & Microbe CDMO Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Live Biotherapeutics Products & Microbe CDMO Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Live Biotherapeutics Products & Microbe CDMO Market Opportunities
  • 3.4.Live Biotherapeutics Products & Microbe CDMO Market Future Trends

4.Live Biotherapeutics Products & Microbe CDMO Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Live Biotherapeutics Products & Microbe CDMO Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Live Biotherapeutics Products & Microbe CDMO Market Landscape

  • 6.1.Live Biotherapeutics Products & Microbe CDMO Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Live Biotherapeutics Products & Microbe CDMO Market - By Service Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 7.1.2.Development Services
    • 7.1.3.Manufacturing Services
    • 7.1.4.Others

8.Live Biotherapeutics Products & Microbe CDMO Market - By Scale of Operation

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
    • 8.1.2.Preclinical Scale Operations
    • 8.1.3.Clinical Scale Operations
    • 8.1.4.Commercial Scale Operations

9.Live Biotherapeutics Products & Microbe CDMO Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.C.difficle
    • 9.1.3.Crohns disease
    • 9.1.4.IBS
    • 9.1.5.Diabetes
    • 9.1.6.Others

10.Live Biotherapeutics Products & Microbe CDMO Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Live Biotherapeutics Products & Microbe CDMO Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.4D Pharma PLC
    • 11.2.2.Catalent, Inc.
    • 11.2.3.Chr. Hansen Holding A/S
    • 11.2.4.Evelo Biosciences, Inc.
    • 11.2.5.Evonik Industries AG
    • 11.2.6.Ferring Pharmaceuticals
    • 11.2.7.Lonza Group AG
    • 11.2.8.Microbiotica Ltd.
    • 11.2.9.Pivot Bio
    • 11.2.10.Rebiotix, Inc. (a Ferring Pharmaceuticals company)
    • 11.2.11.Samsung Biologics
    • 11.2.12.Second Genome, Inc.
    • 11.2.13.Seres Therapeutics, Inc.
    • 11.2.14.Synlogic, Inc.
    • 11.2.15.Vedanta Biosciences, Inc.
    • 11.2.16.Wacker Chemie AG
    • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us